Ibnsina PharmaCAI:ISPH +1.67%85 OCF Yield % is 15.10 as of Jul. 10, 2026, which is 1027% above its 10-year median of 1.34. GuruFocus rates CAI:ISPH with a GF Score™ of 85/100 and a GF Value™ of E£10.51 (Fairly Valued). The stock has 7 warning signs investors should review. Among 116 Medical Distribution companies, Ibnsina Pharma ranks better than 77.59% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ibnsina Pharma OCF Yield % Related Terms
Ibnsina Pharma OCF Yield % Historical Data
* Premium members only.
The historical data trend for Ibnsina Pharma's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ibnsina Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibnsina Pharma OCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Ibnsina Pharma's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ibnsina Pharma (CAI:ISPH) has a OCF Yield % of 15.10 as of Jul. 10, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ibnsina Pharma and its competitors. This is 1027% above median its historical median of 1.34. According to the industry distribution chart, Ibnsina Pharma ranks #26 out of 116 companies in the Medical Distribution industry, placing it in the top 22.4%.
Is Ibnsina Pharma's OCF Yield % too high?
Ibnsina Pharma's current OCF Yield % of 15.10 is 1027% above median its 10-year median of 1.34. The Medical Distribution industry median OCF Yield % is 5.76. Ibnsina Pharma's value of 15.10 is 162.4% above this industry median. Based on the distribution chart, Ibnsina Pharma ranks #26 out of 116 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Ibnsina Pharma has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ibnsina Pharma's OCF Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Ibnsina Pharma ranks #26 out of 116 companies for OCF Yield %. This places Ibnsina Pharma in the top 22% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.76. Ibnsina Pharma's value of 15.10 is 162.4% above this benchmark. While the company's 10-year median is 1.34 vs. the industry median of 5.76, Ibnsina Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Distribution company?
The median OCF Yield % among Medical Distribution companies is 5.76, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ibnsina Pharma's current OCF Yield % of 15.10 is 162.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ibnsina Pharma and its competitors. For the Medical Distribution industry, the median OCF Yield % is 5.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ibnsina Pharma's current OCF Yield % is 15.10, which is 1027% above median its own 10-year median of 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibnsina Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ibnsina Pharma (CAI:ISPH) is currently considered Fairly Valued. The stock's GF Value™ is E£10.51, compared to a current price of E£11.59 — trading 10.3% above its estimated fair value. The current OCF Yield % is 15.10, which is 1027% above median its 10-year median of 1.34 and 162.4% above the Medical Distribution industry median of 5.76. Ibnsina Pharma's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Ibnsina Pharma (CAI:ISPH), the current OCF Yield % is 15.10 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ibnsina Pharma (CAI:ISPH) Overvalued in 2026?
Based on GuruFocus' analysis, Ibnsina Pharma stock appears to be overvalued.
The current stock price of E£11.59 is trading 10.3% above its estimated GF Value™ of E£10.51.
GuruFocus considers Ibnsina Pharma to be Fairly Valued.
Key valuation signals for CAI:ISPH:
OCF Yield %: 15.10 (1027% above median its 10-year median of 1.34)
GF Value™: E£10.51 vs. price of E£11.59 (10.3% above fair value)
Industry Position: 162.4% above the Medical Distribution median (#26 of 116)
No single metric tells the full story. See the CAI:ISPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ibnsina Pharma is an Egypt-based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical, and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, packaging, market research, and analysis.
85GF Score
Get the complete analysis for CAI:ISPH
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:ISPH has been successfully added to your 
